Introduction {#sec1}
============

Transcribed pre-mRNAs are subject to RNA processing in the nucleus, such as capping, polyadenylation, and splicing. Subsequently, processed mRNAs are exported to the cytoplasm ([@ref14]). In some cases, mRNAs are immediately translated, but they can also be transported to various subcellular compartments prior to translation. mRNAs are also turned over in the cytoplasm through regulated decay ([@ref59]). All of these posttranscriptional regulatory steps are important for proper gene expression and are themselves highly regulated. Interaction between RNA-binding proteins (RBPs) and specific cis-regulatory elements in target transcripts is the basis for most posttranscriptional regulation of gene expression ([Figure 1](#fig1){ref-type="fig"}; [@ref96]).

![Posttranscriptional regulations of gene expression by RBPs. After transcription, RBPs bind pre-mRNA and regulate RNA processing in the nucleus. Mature mRNA is transported to cytoplasm by other RBPs. In the cytoplasm, various RBPs control the different mRNA fates, which include localization, translation, and degradation. Collectively, these effects achieve proper gene expression within specific cell types and in response to specific biological regulatory signals. They can also lead to pathological conditions when regulation is compromised, for example, due to mutations in the gene encoding a specific RBP.](fgene-10-00332-g001){#fig1}

Although there are a variety of cis-regulatory elements, for example, the cytoplasmic polyadenylated element (CPE) and the iron responsive element (IRE) ([@ref201]; [@ref204]), we focus here on the AU-rich element (ARE), one important cis-element for RNA regulation, which is typically found in the mRNA 3′ untranslated region (UTR). AREs are contained in 5--8% of human mRNAs coding factors involved in various biological functions such as proliferation, differentiation, signal transduction, apoptosis, and metabolism ([@ref9]; [@ref6]). Originally identified as a sequence inducing mRNA decay ([@ref28]), the ARE was subsequently found to be more broadly involved in RNA processing, transport, and translation ([@ref57]).

Many ARE-binding proteins (ARE-BPs) have been identified that bind to this element and mediate its function in posttranscriptional control ([Table 1](#tab1){ref-type="table"}). Most ARE-BPs characterized to date recognize specific AREs in target mRNAs *via* canonical RNA-binding domains (RBDs), for example, the RNA recognition motif (RRM), CCCH tandem zinc finger domain, and KH domain ([@ref63]; [@ref32]; [@ref101]). However, recently developed techniques have identified many new *bona fide* RBPs and revealed the surprising finding that about half of them do not have a conventional RBD ([@ref23]; [@ref12], [@ref11]). Intriguingly, these noncanonical RBPs include several ARE-BPs and analysis of their potentially contributions to ARE function is underway ([@ref58]).

###### 

The RBDs, targets, and functions of ARE-BPs in this review.

  The features of ARE-binding proteins                                                                                                                                                                                            
  -------------------------------------- ---------------------------- ------------------------------------------------- --------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------
  AUF1                                   Four RRMs                    c-fos, c-myc ([@ref15])                           TNF-α, IL-1β ([@ref84]); c-fos ([@ref15]); c-myc ([@ref82]); GM-CSF? ([@ref105])                          Splicing ([@ref48]); translational repression ([@ref47]); viral replication ([@ref49])
  TTP                                    Tandem zinc finger domains                                                     TNF-α ([@ref75]; [@ref120]); GM-CSF ([@ref76]; [@ref120]); TTP ([@ref17]; [@ref122]); IL-10 ([@ref120])   Translational repression ([@ref121]; [@ref51])
  ZFP36L1                                Tandem zinc finger domains                                                     Dll4 ([@ref38]); CDK6 ([@ref26])                                                                          
  ZFP36L2                                Tandem zinc finger domains                                                     LHR ([@ref26]); H3K4, H3K9 ([@ref40])                                                                     
  KSRP                                   Four KH domains                                                                Myogenin ([@ref61])                                                                                       Viral translation repression ([@ref81]); miRNA maturation ([@ref113]; [@ref123]); splicing ([@ref93])
  HuR                                    Three RRMs                   c-fos, cox2, TNF-α ([@ref70]); SIRT1 ([@ref21])                                                                                                             Translational control in neocortex ([@ref73])
  Nuronal Hu proteins                    Three RRMs                   GAP-43 ([@ref94]); APP, BACE1 ([@ref68])          HuR ([@ref90])                                                                                            Splicing ([@ref48]); translation stimulation ([@ref54]); miRNA attenuation ([@ref53])
  GAPDH                                  Rossmann fold                CSF-1 ([@ref131])                                 Cox-2 ([@ref67]); ET-1 ([@ref111])                                                                        Translational repression ([@ref25])
  LDHM                                   Rossmann fold                                                                  GM-CSF? ([@ref105])                                                                                       Interaction with AUF1 ([@ref105])

Blue colors show canonical ARE-BPs, and red color shows noncanonical ARE-BPs.

A common characteristic of many ARE-BPs is that they shuttle between nucleus and cytoplasm, but they exhibit different functions depending on their localization to control gene expression ([@ref56]). ARE-BP localization and function are both tightly regulated by posttranslational modifications (PTMs) and interactions with other factors ([@ref29]; [@ref118]).

In this review, we summarize (1) the function of ARE-BPs to control mRNA stability or translation in the cytoplasm and RNA processing in the nucleus, (2) the biological and pathological importance of gene regulation by ARE-BPs, and (3) the regulation of ARE-BP function, particularly through PTM.

mRNA Stability and Translational Control by ARE-BPs in the Cytoplasm {#sec2}
====================================================================

AUF1, also known as heterogeneous nuclear ribonucleoprotein D (hnRNP D), was the first identified ARE-BP that can destabilize mRNA ([@ref15]). AUF1-KO mice exhibit symptoms of severe endotoxic shock due to excessive production of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), which results from failure to degrade these mRNAs ([@ref84]). AUF1 was also found to destabilize mRNAs encoding c-fos and c-myc ([@ref15]; [@ref82]), although another study reported that AUF1 stabilizes these mRNAs ([@ref128]). These apparently conflicting results suggest that the function of AUF1 is not fixed, but can be differentially regulated depending on the cell type and specific conditions ([@ref62]). AUF1 forms the AUF1- and signal transduction-regulated complex (ASTRC) with several factors \[eIF4G, poly(A)-binding protein (PABP) C1, Hsp27, and Hsp70\] ([@ref78]; [@ref83]; [@ref119]). This complex is required for AUF1-mediated mRNA decay, but its molecular mechanism of action is still unknown.

TTP is a destabilizing ARE-BP with a well-characterized molecular mechanism. This protein has a tandem zinc finger RBD and binds the 3′UTR of mRNAs coding TNF-α and granulocyte macrophage colony-stimulating factor (GM-CSF), and induces mRNA decay ([@ref76]; [@ref75]). The mRNA coding for TTP also contains AREs in its 3′UTR, and thus, TTP regulates its own expression levels by a negative feedback ([@ref17]; [@ref122]). TTP recruits the CCR4-NOT complex to target mRNAs *via* direct binding to its subunits, CNOT1 and CNOT9 ([@ref42]; [@ref19]). TTP also interacts with the Dcp1a/Dcp2 complex involved in decapping and a component of the exosome, Rrp4, to degrade mRNA ([@ref85]). Furthermore, TTP represses translation by recruitment of 4EHP to target mRNAs through interaction between its PPPPG motif and GYF2 ([Figure 2A](#fig2){ref-type="fig"}; [@ref121]; [@ref51]). 4EHP has affinity for the 5′-end cap structure like eIF4E, but does not bind eIF4G. Therefore, 4EHP represses translation by competing with eIF4E for the cap ([@ref97]). The TIS11 family, to which TTP belongs, also contains two other members, ZFP36L1 and ZFP36L2. Although these factors differ from each other in their tissue distribution and target mRNAs, they have about 70% homology, including the CNOT1 binding site, and both induce mRNA decay ([@ref115]).

![Functional model of destabilizing ARE-BP, TTP and stabilizing ARE-BP, HuD. **(A)** TTP induces mRNA decay by recruiting CCR4-NOT complex, exosome complex, and Dcp1a/Dcp2 complex and represses translation by recruiting 4EHP *via* binding GYF2. **(B)** HuD stimulates translation *via* direct binding to eIF4A and the poly(A) tail. miRISC represses translation by dissociation of eIF4A from the translation initiation complex, and this inhibitory effect on translation initiation is attenuated by HuD. HuD also binds Akt/PKB, which phosphorylates destabilizing ARE-BPs such as KSRP, TTP, ZFP36L1, and ZFP36L2 to inactivate them, and eIF4B to stimulate helicase activity of eIF4A.](fgene-10-00332-g002){#fig2}

K-homology splicing regulatory protein (KSRP) was initially identified as a nuclear factor involved in transcription and splicing ([@ref36]; [@ref93]). Subsequently, it was reported that KSRP binds the ARE using two of four KH domains, KH3 and KH4 ([@ref60]), and destabilizes target mRNAs by recruitment of poly(A)-specific ribonuclease (PARN) and exosome to mRNAs ([@ref27]; [@ref30]). Furthermore, it was shown that KSRP interacts with the enterovirus 71 internal ribosomal entry site (IRES) and behaves as an IRES trans-acting factor (ITAF) to negatively regulate viral translation ([@ref81]).

Unlike the ARE-BPs introduced so far, Hu proteins are ARE-BPs that stabilize their target mRNAs. The Hu protein family consists of four members. HuR is ubiquitously expressed, whereas HuB, HuC, and HuD are mainly expressed in neurons. All members of Hu proteins have three RRMs. RRM1 and RRM2 recognize ARE, and RRM3 binds the poly(A) tail ([@ref86]). HuR binds to the ARE in the mRNAs encoding c-fos, Cox 2, and TNF-α in competition with TTP or KSRP and stabilizes these mRNAs ([@ref46]; [@ref70]). Furthermore, HuR associates with eIF2 alpha kinase 4 and may temporally define translation in the developing neocortex ([@ref73]). Neuronal Hu proteins are thought to regulate and induce neuronal differentiation through stabilizing target mRNAs ([@ref102]; [@ref94]; [@ref1]). Fukao et al. previously showed that HuD stimulates translation initiation *via* direct binding to the poly(A) tail and eIF4A ([@ref54]). Furthermore, Fujiwara et al. demonstrated that physical interaction between HuD and the active form of Akt/PKB is required for morphological alterations such as neurite outgrowth in PC12 cells undergoing a neuronal differentiation program ([@ref52]). Akt/PKB directly phosphorylates eIF4B, whose phosphorylation stimulates the RNA helicase activity of eIF4A ([@ref112]; [@ref4]; [@ref126]). Thus, it is possible that HuD recruits Akt/PKB to the translation initiation complex to stimulate eIF4A activity on its ARE-containing mRNAs ([Figure 2B](#fig2){ref-type="fig"}).

Nuclear Function of ARE-BPs {#sec3}
===========================

Regulation of mRNA stability, localization, and translation is a cytoplasmic function of ARE-BPs, yet most ARE-BPs shuttle between nucleus and cytoplasm, thereby suggesting that these proteins also have nuclear functions. Indeed, several nuclear functions for ARE-BPs have been identified. For example, in recent years, it was shown that KSRP has a novel nuclear function involved in maturation of a subset of microRNAs ([@ref113]; [@ref123]). KSRP binds to a terminal loop of miRNA precursors and promotes both steps of biogenesis: conversion of pri-miRNAs to pre-miRNAs in the nucleus by Drosha and pre-miRNA processing to mature miRNAs in the cytoplasm by Dicer ([@ref123]).

Hu proteins have a domain regulating nuclear-cytoplasmic shuttling located in a linker region between RRM2 and RRM3 ([@ref45]; [@ref69]). A recent study showed that AREs are abundant in introns of human genes and that HuR regulates expression of genes containing these intronic AREs ([@ref5]). The pre-mRNAs coding for HuR undergo alternative polyadenylation leading to transcript variants with different lengths of 3′UTR and stability ([@ref3]). Because HuR impairs neuronal differentiation by promoting cell proliferation, neuronal Hu proteins decrease HuR expression by binding to the pre-mRNA of HuR at the polyadenylation site to produce a less stable mRNA bearing the long 3′UTR ([@ref90]). Neuronal Hu proteins are also involved in neuron-specific alternative splicing by utilizing AUF1 as a co-factor ([@ref48]).

TIS11 family proteins have a potential nuclear localization signal within the zinc finger domain ([@ref99]; [@ref103]; [@ref125]). In the nucleus, TTP in association with poly(A)-binding protein nuclear 1 (PABPN1) inhibits poly(A) tail synthesis on mRNAs which contain AREs, such as TNF-α, GM-CSF, and IL-10, thereby promoting degradation of these transcripts ([@ref120]). Under hypoxia, ZFP36L1 has been reported to reduce expression level of Delta-like 4 (Dll4) involved in cell fate determination in angiogenesis by inhibiting cleavage at the polyadenylation site of the *Dll4* mRNA ([@ref74]; [@ref38]).

Noncanonical ARE-BPs {#sec4}
====================

Recently, systematic investigation of RBPs has been performed in various cell types (yeast and cultured cells) by interactome capture assays ([@ref23]; [@ref12], [@ref11]). Protein-RNA interactions are immobilized by conventional UV crosslinking (cCL) by 254 nm UV irradiation or photoactivatable ribonucleoside-enhanced (PAR-) CL by 365 nm UV irradiation using cells by which photoactivatable 4-thiouridine (4 SU) is taken up. Then, mRNA-RBP complexes are captured by oligo(dT) beads, and the proteins are analyzed by mass spectrometry after digestion of mRNAs. As a result, many novel RBPs were detected. Surprisingly, about half of these have no conventional RBD ([@ref23]; [@ref12], [@ref11]). Many well-known metabolic enzymes are among these noncanonical RBPs. A typical example of a metabolic enzyme that has been identified as noncanonical RBP is ACO1/IRP1. When iron levels are in the normal physiological range, ACO1/IRP1 functions as a cytoplasmic aconitase in the TCA cycle. However, in iron-deficient conditions, ACO1/IRP1 behaves as a sequence-specific RBP that recognizes a certain stem-loop structure, the iron-responsive element (IRE) ([@ref33]). ACO1/IRP1 binds the 3′UTR of the mRNA coding transferrin involved in iron uptake and stabilizes this mRNA ([@ref22]; [@ref98]). It also binds to an IRE in the 5′UTR of the mRNA encoding ferritin, a protein involved in iron storage. In this case, it inhibits translation ([@ref64]), thereby regulating the intracellular iron level. This classic example of a metabolic enzyme moonlighting as an RBP illustrates how cellular metabolic states can be intimately connected with posttranscriptional regulation of gene expression ([@ref24]).

Further evidence to support this principle is found in the glycolytic enzyme, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which is a noncanonical ARE-BP ([@ref100]). GAPDH binds the ARE *via* a Rossmann fold which binds NAD^+^/NADH, and thus, NAD^+^ abundance affects binding activity of GAPDH to the ARE ([@ref100]; [@ref111]; [@ref67]). Indeed, a switch from oxidative phosphorylation to aerobic glycolysis when T lymphocytes are activated promotes dissociation of GAPDH from the ARE in the mRNA coding for interferon-γ (IFN-γ) and increases expression of IFN-γ ([@ref25]). GAPDH also binds to mRNAs containing AREs, such as those encoding colony stimulating factor-1 (CSF-1), cyclooxygenase-2 (Cox-2), and endothelin-1 (ET-1), and regulates stability or translation of these mRNAs ([@ref111]; [@ref131]; [@ref67]). Likewise, lactate dehydrogenase (LDH) M, which is a glycolytic enzyme, also binds an ARE in the mRNA coding for GM-CSF by a Rossmann fold in an NAD^+^ concentration-dependent manner ([@ref105]). Moreover, LDHM directly interacts with AUF1. This interaction is thought to complement low binding specificity of AUF1, which also binds various RNAs even without AREs ([@ref72]; [@ref41]), and to be utilized for recruitment of AUF1 to target mRNAs ([@ref105]).

Biological Functions of ARE-BPs in Health and Disease {#sec5}
=====================================================

The fact that AREs are found mainly in mRNAs coding for inflammatory cytokines and growth factors suggests the potential for coordinated regulation of specific biological processes by ARE-BPs ([@ref9]; [@ref71]; [@ref124]).

ZFP36L1 and ZFP36L2 have redundant functions in T-cell and B-cell maturation ([@ref65]; [@ref55]). During T-cell maturation, ZFP36L1 and ZFP36L2 limit the cell cycle and repress the DNA damage response induced by double-strand DNA breaks ([@ref127]). Moreover, ZFP36L1 promotes monocyte/macrophage differentiation by controlling mRNA stability of CDK6 ([@ref26]). It was reported that mice that lack the N-terminal 29 amino acids of ZFP36L2 are infertile ([@ref109]; [@ref108]), due to failure to control expression of luteinizing hormone receptor (LHR) by ZFP36L2 ([@ref7]). More recently, oocyte-specific KO of ZFP36L2 in mice showed that this protein controls expression of histone demethylases targeting H3K4 and H3K9 and induces global transcriptional silencing in the oocyte, which is important for the oocyte-to-embryo transition ([@ref40]).

Neuronal Hu proteins are involved in alternative splicing of amyloid precursor protein (APP) ([@ref48]). The APP gene contains 18 exons and 3 isoforms: APP770 contains all exons, APP751 lacks exon 8, and APP695 lacks exons 7 and 8. In the brain of Alzheimer's disease patients, APP695 is decreased, whereas APP770 is increased ([@ref95]; [@ref92]). Neuronal Hu proteins promote expression of APP695 instead of APP770 ([@ref48]). On the other hand, HuD stabilizes the mRNAs for APP, as well as β-site APP-cleaving enzyme 1 (BACE1), which induces processing from APP to amyloid-β ([@ref68]).

ARE-BPs are also implicated in other neurological disorders. A human genetics study identified TIA1 mutations in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients ([@ref87]). Interestingly, this same study showed that these mutations promote phase separation of TIA1 protein and affect the dynamics of stress granules, which are themselves suggested to be important in ALS pathology ([@ref79]; [@ref130]).

HuD may also be involved in ALS and another neurological disorder, spinal muscular atrophy (SMA). Direct evidence for a contribution of HuD to ALS is lacking, but it was found to form insoluble aggregates in the cytoplasm with TDP-43, an RBP heavily implicated in ALS and FTD ([@ref43]), thereby raising the possibility of pathological interactions between these two RBPs. In addition to nuclear functions in pre-mRNA processing, TDP-43 also represses translation of specific mRNAs in *Drosophila* ALS models and cultured mammalian cells ([@ref88], [@ref89]; [@ref35], [@ref34]), although the exact connection between these mRNAs and ALS remains unclear. More recently, TDP-43 was also shown to function as an mRNA-specific translational enhancer for the mRNAs encoding CAMTA1 and DENND4, both of which are directly linked to ALS and neurodegenerative disease ([@ref202]). Whether HuD contributes to this regulation remains to be determined. However, the *Camta1* and *Dennd4a* mRNAs both contain many AREs based on *in silico* analyses ([@ref44]). This observation, taken together with HuD's ability to function as an mRNA-specific translational enhancer *via* AREs ([@ref54]), raises the possibility that HuD might potentially function as a co-factor in TDP-43-driven translational enhancement of *Camta1* and *Dennd4a* mRNAs.

SMA is caused by lack or mutation of survival of motor neuron protein (SMN) ([@ref20]). SMN interacts with HuD on mRNAs such as the one coding for candidate plasticity-related gene 15 (cpg15), and forms an RNA granule ([@ref2]; [@ref43]; [@ref66]). The tudor domain of SMN is important for interaction between SMN and HuD, and an SMN mutant from severe SMA patients bearing a mutation in the Tudor domain cannot interact with HuD ([@ref18]; [@ref43]; [@ref66]). What does this interaction between HuD and SMN mean? We previously reported translation stimulation by HuD ([@ref54]). Another group showed that SMN represses translation of certain mRNAs, and the Tudor domain mutant of SMN is not able to repress translation ([@ref114]). Repression of ectopic translation and induction of translation initiation in response to local stimulatory cues are important components of local translation in neuronal compartments. Moreover, SMN is closely involved in axonal translation ([@ref200]). Therefore, an interesting possibility is that SMN and HuD could have opposite, but complementary, roles in the context of neuronal mRNP transport and translation. According to this view, SMN could function as a brake to suppress ectopic translation while mRNPs are transported to sites where local protein synthesis would occur. Conversely, HuD's role would be to promote translation initiation at these sites in response to local neuronal cues. Future studies in primary neuronal cultures could examine this possibility.

Regulation of ARE-BP Function {#sec6}
=============================

As can be seen from the examples of SMN and HuD, functional regulation of ARE-BPs is strongly related to biological functions and diseases. Thus, function of ARE-BPs is controlled by several factors such as long noncoding (lnc) RNA, other proteins, and PTMs.

H19 is an lncRNA expressed in embryo and skeletal muscle ([@ref10]). A recent study showed that H19 directly binds KSRP and promotes destabilization of the mRNA for myogenin by KSRP, thus favoring myogenic differentiation ([@ref61]). Overexpressed in colon carcinoma-1 (OCC-1), an lncRNA binds HuR and enhances binding of the β-TrCP1 E3-ubiquitin ligase, thereby promoting destabilization of the HuR protein ([@ref104]; [@ref77]).

Arginine methylation is a common feature of a large population of RGG box proteins, which are involved in many aspects of mRNA metabolism ([@ref107]). In some cases, arginine methylation has been shown to regulate the function of ARE-BPs containing RGG boxes. For example, HuR is methylated at R217 by coactivator-associated arginine methyltransferase 1 (CARM1) and methylated HuR binds the mRNA encoding the histone deacetylase, Sirtuin 1 (SIRT1) to stabilize it ([@ref21]). Many hnRNP proteins that contain RGG boxes are also subject to arginine methylation, thereby potentially affecting their localization and RNA-binding activity ([@ref129]). However, while it was reported that hnRNP D/AUF1 is methylated, this did not seem to affect either localization or RNA-binding activity of AUF1 ([@ref37]; [@ref116]). Recently, it was shown that arginine methylation of AUF1 is involved in translational repression of the mRNA coding for vascular endothelial growth factor (VEGF) ([@ref47]). Furthermore, this PTM also affects AUF1's role as a host factor during the replication of the West Nile virus genome ([@ref49]) In this case, arginine methylation of AUF1 by protein arginine N-methyltransferase 1 (PRMT1) promotes AUF1 function as an RNA chaperone ([@ref50]).

Many ARE-BPs are phosphorylated. In some cases, the regulatory effects of phosphorylation, as well as the signaling pathways and kinases responsible, have been determined. For example, KSRP has two independent phosphorylation sites in its C-terminal and KH1 domains ([@ref16]; [@ref39]). The C-terminal Thr692 of KSRP is phosphorylated by p38/MAPK to promote destabilization of target mRNAs ([@ref16]). On the other hand, Ser193 in the KH1 domain is phosphorylated by Akt/PKB to localize KSRP in the nucleus *via* binding of 14-3-3 proteins, thereby inhibiting mRNA decay in the cytoplasm ([@ref39]). TIS11 family proteins, TTP, and ZFP36L1 and ZFP36L2 are also phosphorylated by p38/MAPK or Akt/PKB and recognized by 14-3-3 proteins ([@ref31]; [@ref117]; [@ref13]). Phosphorylation of TTP at Ser52 and Ser178 reduces interaction with the CCR4-NOT complex and thereby upregulates mRNA stability ([@ref91]). Conversely, phosphorylation at Ser334 of ZFP36L1 also decreases interaction with the CCR4-NOT complex, but increases affinity to Dcp1a to promote mRNA decay ([@ref110]).

HuD is subject to phosphorylation by PKC to promote its mRNA stabilizing activity ([@ref80]). On the other hand, we previously demonstrated that HuD interacts with Akt/PKB, although Akt/PKB does not lead to HuD phosphorylation ([@ref52]). This interaction might recruit Akt/PKB, which phosphorylates and inactivates destabilizing ARE-BPs such as KSRP and TIS11 family proteins, to ARE-containing mRNAs. This suggests that HuD can not only compete with destabilizing ARE-BPs but also potentially inactivate them on the same mRNA through phosphorylation by Akt/PKB to stabilize mRNA. We also showed that HuD attenuates translational repression by the miRNA-induced silencing complex (miRISC), which leads to mRNA decay as well as destabilizing ARE-BPs ([@ref53]). These observations support a central role for HuD in stabilizing mRNA and promoting translation ([Figure 2B](#fig2){ref-type="fig"}).

Conclusion and Perspectives {#sec7}
===========================

The ARE has been studied for a long time, and about 20 ARE-BPs have been identified since discovery of first ARE-BP, AUF1 ([@ref15]; [@ref57]). The specific target mRNAs for different ARE-BPs, as well as their molecular functions on these mRNAs, and contribution of this regulation to specific biological processes are gradually being uncovered. However, with a few exceptions, the molecular mechanisms used by ARE-BPs to regulate their targets are still unknown. In particular, the mechanism to recognize and control specific targets from the large number of transcripts that have AREs is an open question. Recently, Ball et al. revealed that ZFP36L2, but not ZFP36L1, recognizes one of three AREs in 3′UTR of mRNA coding LHR, and this ARE is located within a hairpin structure ([@ref7], [@ref8]). This indicates that not only the ARE sequence but also proximal RNA secondary structure affects the binding specificity of ARE-BPs. Future experimental and *in silico* approaches to understand the determinants of ARE recognition by specific ARE-BPs' analysis will thus be needed to incorporate RNA structure, as well as sequence. Moreover, as shown in the example of LDHM and AUF1 ([@ref105]), it will also be necessary to study the influence of the interaction between ARE-BPs on specific ARE recognition and molecular regulatory mechanisms on the same transcripts. Finally, systematic studies have shown that the relative spacing of 3′UTR cis-elements and associated regulatory proteins can have strong contextual effects on regulation ([@ref106]). Thus, to understand fully ARE-BP function and mechanism, it will be important to examine interplay between AREs, ARE-BPs, and other neighboring cis-elements within specific 3′UTRs.
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